Patient 3 must be getting close to their 6 weeks. Approval for 2 simultaneous patients would have to indicate all is good. Hopefully the company will start talking indications from the first 3.
Does anyone know what or how we are taking care of our brave patients when their observation periods have passed?
- Forums
- ASX - By Stock
- BLT
- Sanofi Signs Benitec's closest competitor Voyager for $845M
Sanofi Signs Benitec's closest competitor Voyager for $845M, page-15
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne